nach oben

Current Oral Health Reports

Erschienen in:

14.01.2020 | Host Parasite Interactions in Periodontal Disease (C Genco and D Kinane, Section Editors)

The Gastrointestinal Microbiome in Chronic Renal Diseases

verfasst von: Mark A. Bryniarski, Sarah E. M. Hoffman, Rabi Yacoub

Erschienen in: Current Oral Health Reports | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The relationship between microorganisms within the gastrointestinal tract and the renal function of the host is reciprocal. The objective of the current review is therefore twofold. First, we aim to demonstrate the emerging role of gastrointestinal microbiome dysbiosis in the pathogenesis and progression of chronic kidney disease. Second, we highlight specific mechanisms as to how microbiome dysbiosis is provoked in chronic kidney disease.

Recent Findings

Current work has shown that microbiome dysbiosis can directly and indirectly influence renal physiology and contribute to the onset and development of chronic kidney disease, such as by stimulating hypertension. It is also becoming evident that the composition and function of both the intestinal and oral microbiomes are adversely impacted by chronic kidney disease, which can further exacerbate dysbiosis.

Summary

This review discusses the current knowledge on the associations between the gastrointestinal microbiome and renal health, to which Dr. Robert Genco has contributed substantially. As we mourn his loss, we celebrate his lifelong dedication to the advancement of research at the University at Buffalo and the microbiome research community worldwide.

Chaves LD, McSkimming DI, Bryniarski MA, Honan AM, Abyad S, Thomas SA et al. Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis. Am J Physiol Renal Physiol. 2018;315(3):F487-F502. doi:https://doi.org/10.1152/ajprenal.00092.2018.PubMedPubMedCentral

Yacoub R, Nugent M, Cai W, Nadkarni GN, Chaves LD, Abyad S et al. Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial. PLoS One. 2017;12(9):e0184789. doi:https://doi.org/10.1371/journal.pone.0184789.PubMedPubMedCentral

Yacoub R, Nadkarni GN, McSkimming DI, Chaves LD, Abyad S, Bryniarski MA et al. Fecal microbiota analysis of polycystic kidney disease patients according to renal function: a pilot study. Exp Biol Med (Maywood). 2019;244(6):505–13. doi:https://doi.org/10.1177/1535370218818175.PubMedPubMedCentral

Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000;71(10):1554–60. doi:https://doi.org/10.1902/jop.2000.71.10.1554.PubMed

Glurich I, Grossi S, Albini B, Ho A, Shah R, Zeid M et al. Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin Diagn Lab Immunol. 2002;9(2):425–32. doi:https://doi.org/10.1128/cdli.9.2.425-432.2002.

Genco R, Offenbacher S, Beck J. Periodontal disease and cardiovascular disease: epidemiology and possible mechanisms. J Am Dent Assoc. 2002;133 Suppl:14S–22S. doi:https://doi.org/10.14219/jada.archive.2002.0375.PubMed

Hajishengallis G, Martin M, Schifferle RE, Genco RJ. Counteracting interactions between lipopolysaccharide molecules with differential activation of toll-like receptors. Infect Immun. 2002;70(12):6658–64. doi:https://doi.org/10.1128/iai.70.12.6658-6664.2002.PubMedPubMedCentral

Mougeot JC, Stevens CB, Paster BJ, Brennan MT, Lockhart PB, Mougeot FK. Porphyromonas gingivalis is the most abundant species detected in coronary and femoral arteries. J Oral Microbiol. 2017;9(1):1281562. doi:https://doi.org/10.1080/20002297.2017.1281562.

LaMonte MJ, Genco RJ, Hovey KM, Wallace RB, Freudenheim JL, Michaud DS et al. History of periodontitis diagnosis and edentulism as predictors of cardiovascular disease, stroke, and mortality in postmenopausal women. J Am Heart Assoc. 2017;6(4). doi:https://doi.org/10.1161/JAHA.116.004518.

10.

Gordon JH, LaMonte MJ, Genco RJ, Zhao J, Li L, Hovey KM et al. Is the oral microbiome associated with blood pressure in older women? High Blood Press Cardiovasc Prev. 2019;26(3):217–25. doi:https://doi.org/10.1007/s40292-019-00322-8.

11.

Gordon JH, LaMonte MJ, Zhao J, Genco RJ, Cimato TR, Hovey KM et al. Association of periodontal disease and edentulism with hypertension risk in postmenopausal women. Am J Hypertens. 2019;32(2):193–201. doi:https://doi.org/10.1093/ajh/hpy164.PubMedCentral

12.

Gordon JH, LaMonte MJ, Genco RJ, Zhao J, Cimato TR, Hovey KM et al. Association of clinical measures of periodontal disease with blood pressure and hypertension among postmenopausal women. J Periodontol. 2018;89(10):1193–202. doi:https://doi.org/10.1002/JPER.17-0562.PubMedPubMedCentral

13.

Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, Knowler WC et al. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol. 1996;67 Suppl 10S:1085–93. doi:https://doi.org/10.1902/jop.1996.67.10s.1085.PubMed

14.

Jiao N, Baker SS, Nugent CA, Tsompana M, Cai L, Wang Y et al. Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: a meta-analysis. Physiol Genomics. 2018;50(4):244–54. doi:https://doi.org/10.1152/physiolgenomics.00114.2017.PubMed

15.

CDC. Chronic kidney disease in the United States, 2019. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention. 2019.

16.

Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–35. doi:https://doi.org/10.1053/j.ajkd.2014.01.416.PubMed

17.

Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017;390(10105):1888–917. doi:https://doi.org/10.1016/S0140-6736(17)30788-2.

18.

Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell. 2012;148(6):1258–70. doi:https://doi.org/10.1016/j.cell.2012.01.035.PubMedPubMedCentral

19.

Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220–30. doi:https://doi.org/10.1038/nature11550.PubMedPubMedCentral

20.

Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500(7464):541–6. doi:https://doi.org/10.1038/nature12506.PubMed

21.

Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–14. doi:https://doi.org/10.1038/nature11234.

22.

Darkoh C, Plants-Paris K, Bishoff D, DuPont HL. Clostridium difficile modulates the gut microbiota by inducing the production of indole, an interkingdom signaling and antimicrobial molecule. mSystems. 2019;4(2). doi:https://doi.org/10.1128/mSystems.00346-18.

23.

Taubman MA. Robert J. Genco: Pioneer in oral science advancement. J Dent Res. 2018;97(7):737–41. doi:https://doi.org/10.1177/0022034518770607.PubMed

24.••

Jansen J, Jansen K, Neven E, Poesen R, Othman A, van Mil A et al. Remote sensing and signaling in kidney proximal tubules stimulates gut microbiome-derived organic anion secretion. Proceedings of the National Academy of Sciences of the United States of America. 2019;116(32):16105–10. doi:https://doi.org/10.1073/pnas.1821809116. Thorough study demonstrating that bacterial metabolites generated within the intestine can influence aspects of renal function.

25.

Shah NB, Allegretti AS, Nigwekar SU, Kalim S, Zhao S, Lelouvier B et al. Blood microbiome profile in CKD: a pilot study. Clin J Am Soc Nephrol. 2019;14(5):692–701. doi:https://doi.org/10.2215/CJN.12161018.PubMedPubMedCentral

26.••

Kikuchi K, Saigusa D, Kanemitsu Y, Matsumoto Y, Thanai P, Suzuki N et al. Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease. Nat Commun. 2019;10(1):1835. doi:https://doi.org/10.1038/s41467-019-09735-4. This group characterized phenyl sulfate renal toxicology and showed that lowering its production reduced albuminuria in diabetic animals.

27.

Wallace K, Shafique S, Piamjariyakul U. The Relationship Between Oral Health and hemodialysis treatment among adults with chronic kidney disease: a systematic review. Nephrol Nurs J. 2019;46(4):375–94.

28.

Araujo MV, Hong BY, Fava PL, Khan S, Burleson JA, Fares G et al. End stage renal disease as a modifier of the periodontal microbiome. BMC Nephrol. 2015;16:80. doi:https://doi.org/10.1186/s12882-015-0081-x.

29.••

Hu J, Iragavarapu S, Nadkarni GN, Huang R, Erazo M, Bao X et al. Location-specific oral microbiome possesses features associated with CKD. Kidney Int Rep. 2018;3(1):193–204. doi:https://doi.org/10.1016/j.ekir.2017.08.018. One of only a handful of studies examining oral microbiome changes in CKD, this study detailed localized microbiome alterations within the mouths of CKD patients. PubMed

30.

Piccolo M, De Angelis M, Lauriero G, Montemurno E, Di Cagno R, Gesualdo L et al. Salivary microbiota associated with immunoglobulin A nephropathy. Microb Ecol. 2015;70(2):557–65. doi:https://doi.org/10.1007/s00248-015-0592-9.PubMed

31.

Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol. 2014;25(4):657–70. doi:https://doi.org/10.1681/ASN.2013080905.PubMedPubMedCentral

32.•

Meijers B, Evenepoel P, Anders HJ. Intestinal microbiome and fitness in kidney disease. Nat Rev Nephrol. 2019;15(9):531–45. doi:https://doi.org/10.1038/s41581-019-0172-1. This review highlighted the notion of viewing the microbiome and the host in the context of ecology and fitness. It then provided considerable information on the various aspects of intestinal microbiome dysbiosis in CKD. PubMed

33.

Yang T, Richards EM, Pepine CJ, Raizada MK. The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease. Nat Rev Nephrol. 2018;14(7):442–56. doi:https://doi.org/10.1038/s41581-018-0018-2.PubMedPubMedCentral

34.•

Zubcevic J, Richards EM, Yang T, Kim S, Sumners C, Pepine CJ et al. Impaired autonomic nervous system-microbiome circuit in hypertension. Circ Res. 2019;125(1):104–16. doi:https://doi.org/10.1161/CIRCRESAHA.119.313965. A recent and insightful review that discussed the contribution and mechanisms of intestinal microbiome dysbiosis in hypertension. PubMedPubMedCentral

35.

Pluznick JL. Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors. Kidney Int. 2016;90(6):1191–8. doi:https://doi.org/10.1016/j.kint.2016.06.033.PubMedPubMedCentral

36.

Bryniarski MA, Hamarneh F, Yacoub R. The role of chronic kidney disease-associated dysbiosis in cardiovascular disease. Experimental biology and medicine. 2019;244(6):514–25. doi:https://doi.org/10.1177/1535370219826526.PubMedPubMedCentral

37.

Jovanovich A, Isakova T, Stubbs J. Microbiome and cardiovascular disease in CKD. Clin J Am Soc Nephrol. 2018;13(10):1598–604. doi:https://doi.org/10.2215/CJN.12691117.

38.

Li DY, Tang WHW. Contributory role of gut microbiota and their metabolites toward cardiovascular complications in chronic kidney disease. Semin Nephrol. 2018;38(2):193–205. doi:https://doi.org/10.1016/j.semnephrol.2018.01.008.PubMedPubMedCentral

39.

National Institutes of Health N. United States Renal Data System. 2018 USRDS annual data report: epidemiology of kidney disease in the United States. Bethesda, MD. 2018.

40.

Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. The Journal of clinical investigation. 2011;121(6):2126–32. doi:https://doi.org/10.1172/JCI58109.

41.

Thaiss CA, Itav S, Rothschild D, Meijer MT, Levy M, Moresi C et al. Persistent microbiome alterations modulate the rate of post-dieting weight regain. Nature. 2016;540(7634):544–51. doi:https://doi.org/10.1038/nature20796.PubMed

42.

Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555(7695):210–5. doi:https://doi.org/10.1038/nature25973.PubMed

43.

David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–63. doi:https://doi.org/10.1038/nature12820.PubMedPubMedCentral

44.

Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334(6052):105–8. doi:https://doi.org/10.1126/science.1208344.PubMedPubMedCentral

45.

Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163(5):1079–94. doi:https://doi.org/10.1016/j.cell.2015.11.001.PubMed

46.

Allen JM, Mailing LJ, Niemiro GM, Moore R, Cook MD, White BA et al. Exercise alters gut microbiota composition and function in lean and obese humans. Med Sci Sports Exerc. 2018;50(4):747–57. doi:https://doi.org/10.1249/MSS.0000000000001495.

47.

Sonnenburg ED, Smits SA, Tikhonov M, Higginbottom SK, Wingreen NS, Sonnenburg JL. Diet-induced extinctions in the gut microbiota compound over generations. Nature. 2016;529(7585):212–5. doi:https://doi.org/10.1038/nature16504.PubMedPubMedCentral

48.•

Riva A, Kuzyk O, Forsberg E, Siuzdak G, Pfann C, Herbold C et al. A fiber-deprived diet disturbs the fine-scale spatial architecture of the murine colon microbiome. Nat Commun. 2019;10(1):4366. doi:https://doi.org/10.1038/s41467-019-12413-0. A very intersting article that identified the spatial profile of diet-induced microbiome changes and the impact on the host epithelia.

49.

Bier A, Braun T, Khasbab R, Di Segni A, Grossman E, Haberman Y et al. A high salt diet modulates the gut microbiota and short chain fatty acids production in a salt-sensitive hypertension rat model. Nutrients. 2018;10(9). doi:https://doi.org/10.3390/nu10091154.PubMedCentral

50.

Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027–31. doi:https://doi.org/10.1038/nature05414.PubMed

51.

Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Science translational medicine. 2009;1(6):6ra14. doi:https://doi.org/10.1126/scitranslmed.3000322.PubMedPubMedCentral

52.•

Martin AM, Yabut JM, Choo JM, Page AJ, Sun EW, Jessup CF et al. The gut microbiome regulates host glucose homeostasis via peripheral serotonin. Proceedings of the National Academy of Sciences of the United States of America. 2019;116(40):19802–4. doi:https://doi.org/10.1073/pnas.1909311116. A study that provided a novel mechanism as to how the intestinal microbiome is capable of influencing the systemic glucose homeostasis of its host.

53.

Costello EK, Stagaman K, Dethlefsen L, Bohannan BJ, Relman DA. The application of ecological theory toward an understanding of the human microbiome. Science. 2012;336(6086):1255–62. doi:https://doi.org/10.1126/science.1224203.PubMedPubMedCentral

54.

Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature. 2007;449(7164):811–8. doi:https://doi.org/10.1038/nature06245.PubMed

55.

Wahlstrom A, Sayin SI, Marschall HU, Backhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell metabolism. 2016;24(1):41–50. doi:https://doi.org/10.1016/j.cmet.2016.05.005.PubMed

56.

Koh A, De Vadder F, Kovatcheva-Datchary P, Backhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332–45. doi:https://doi.org/10.1016/j.cell.2016.05.041.PubMed

57.

Thaiss CA, Zmora N, Levy M, Elinav E. The microbiome and innate immunity. Nature. 2016;535(7610):65–74. doi:https://doi.org/10.1038/nature18847.

58.

Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature. 2016;535(7610):75–84. doi:https://doi.org/10.1038/nature18848.PubMed

59.

Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012;482(7384):179–85. doi:https://doi.org/10.1038/nature10809.PubMedPubMedCentral

60.

Chimerel C, Emery E, Summers DK, Keyser U, Gribble FM, Reimann F. Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. Cell Rep. 2014;9(4):1202–8. doi:https://doi.org/10.1016/j.celrep.2014.10.032.PubMed

61.

Grasset E, Puel A, Charpentier J, Collet X, Christensen JE, Terce F et al. A specific gut microbiota dysbiosis of type 2 diabetic mice induces GLP-1 resistance through an enteric no-dependent and gut-brain axis mechanism. Cell metabolism. 2017;25(5):1075–90 e5. doi:https://doi.org/10.1016/j.cmet.2017.04.013.PubMed

62.

Meyer TW, Hostetter TH. Uremic solutes from colon microbes. Kidney Int. 2012;81(10):949–54. doi:https://doi.org/10.1038/ki.2011.504.PubMed

63.

Meijers BK, Bammens B, Verbeke K, Evenepoel P. A review of albumin binding in CKD. Am J Kidney Dis. 2008;51(5):839–50. doi:https://doi.org/10.1053/j.ajkd.2007.12.035.PubMed

64.

Meyer TW, Hostetter TH. Uremia. The New England journal of medicine. 2007;357(13):1316–25. doi:https://doi.org/10.1056/NEJMra071313.

65.

Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R et al. Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012;23(7):1258–70. doi:https://doi.org/10.1681/ASN.2011121175.PubMedPubMedCentral

66.•

Mair RD, Sirich TL, Plummer NS, Meyer TW. Characteristics of colon-derived uremic solutes. Clin J Am Soc Nephrol. 2018;13(9):1398–404. doi:https://doi.org/10.2215/CJN.03150318. This work was a comprehensive characterization of uremic solutes originating from the colon. PubMedPubMedCentral

67.

Vaziri ND, Zhao YY, Pahl MV. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment. Nephrol Dial Transplant. 2016;31(5):737–46. doi:https://doi.org/10.1093/ndt/gfv095.

68.

Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R. Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol. 2009;4(6):1089–96. doi:https://doi.org/10.2215/CJN.00290109.PubMedPubMedCentral

69.

Zoccali C, Vanholder R, Massy ZA, Ortiz A, Sarafidis P, Dekker FW et al. The systemic nature of CKD. Nat Rev Nephrol. 2017;13(6):344–58. doi:https://doi.org/10.1038/nrneph.2017.52.PubMed

70.

Magnusson M, Magnusson KE, Sundqvist T, Denneberg T. Increased intestinal permeability to differently sized polyethylene glycols in uremic rats: effects of low- and high-protein diets. Nephron. 1990;56(3):306–11. doi:https://doi.org/10.1159/000186158.PubMed

71.

Magnusson M, Magnusson KE, Sundqvist T, Denneberg T. Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure. Gut. 1991;32(7):754–9. doi:https://doi.org/10.1136/gut.32.7.754.PubMedPubMedCentral

72.

Vaziri ND, Dure-Smith B, Miller R, Mirahmadi MK. Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases. The American journal of gastroenterology. 1985;80(8):608–11.

73.

Vaziri ND, Yuan J, Nazertehrani S, Ni Z, Liu S. Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction. Am J Nephrol. 2013;38(2):99–103. doi:https://doi.org/10.1159/000353764.PubMed

74.

Vaziri ND, Goshtasbi N, Yuan J, Jellbauer S, Moradi H, Raffatellu M et al. Uremic plasma impairs barrier function and depletes the tight junction protein constituents of intestinal epithelium. Am J Nephrol. 2012;36(5):438–43. doi:https://doi.org/10.1159/000343886.PubMed

75.

Vaziri ND, Yuan J, Norris K. Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease. Am J Nephrol. 2013;37(1):1–6. doi:https://doi.org/10.1159/000345969.PubMed

76.

Andrade LS, Dalboni MA, Carvalho JTG, Grabulosa CC, Pereira NBF, Aoike DT et al. In vitro effect of uremic serum on barrier function and inflammation in human colonocytes. J Bras Nefrol. 2018;40(3):217–24. doi:https://doi.org/10.1590/2175-8239-JBN-3949.PubMedPubMedCentral

77.

Shi K, Wang F, Jiang H, Liu H, Wei M, Wang Z et al. Gut bacterial translocation may aggravate microinflammation in hemodialysis patients. Digestive diseases and sciences. 2014;59(9):2109–17. doi:https://doi.org/10.1007/s10620-014-3202-7.PubMed

78.

McIntyre CW, Harrison LE, Eldehni MT, Jefferies HJ, Szeto CC, John SG et al. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(1):133–41. doi:https://doi.org/10.2215/CJN.04610510.PubMed

79.

Andersen K, Kesper MS, Marschner JA, Konrad L, Ryu M, Kumar Vr S et al. Intestinal dysbiosis, barrier dysfunction, and bacterial translocation account for CKD-related systemic inflammation. J Am Soc Nephrol. 2017;28(1):76–83. doi:https://doi.org/10.1681/ASN.2015111285.PubMedPubMedCentral

80.

Meijers B, Farre R, Dejongh S, Vicario M, Evenepoel P. Intestinal barrier function in chronic kidney disease. Toxins (Basel). 2018;10(7). doi:https://doi.org/10.3390/toxins10070298.PubMedCentral

81.

Mair RD, Sirich TL. Blood microbiome in CKD: should we care? Clin J Am Soc Nephrol. 2019;14(5):648–9. doi:https://doi.org/10.2215/CJN.03420319.PubMedPubMedCentral

82.

Niwa T. The protein metabolite theory as a mechanism for the progression of renal failure. J Ren Nutr. 2001;11(4):181–2.PubMed

83.

Watanabe H, Miyamoto Y, Honda D, Tanaka H, Wu Q, Endo M et al. p-cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int. 2013;83(4):582–92. doi:https://doi.org/10.1038/ki.2012.448.

84.

Janeiro MH, Ramirez MJ, Milagro FI, Martinez JA, Solas M. Implication of trimethylamine N-oxide (TMAO) in disease: potential biomarker or new therapeutic target. Nutrients. 2018;10(10). doi:https://doi.org/10.3390/nu10101398.PubMedCentral

85.

Tang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116(3):448–55. doi:https://doi.org/10.1161/CIRCRESAHA.116.305360.PubMed

86.

Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5(1):14. doi:https://doi.org/10.1186/s40168-016-0222-x.

87.•

Toral M, Robles-Vera I, de la Visitacion N, Romero M, Yang T, Sanchez M et al. Critical role of the interaction gut microbiota-sympathetic nervous system in the regulation of blood pressure. Front Physiol. 2019;10:231. doi:https://doi.org/10.3389/fphys.2019.00231. This study measured the ability of the microbiome to cause or decrease hypertension via fecal matter transplant studies.

88.

Wilck N, Matus MG, Kearney SM, Olesen SW, Forslund K, Bartolomaeus H et al. Salt-responsive gut commensal modulates TH17 axis and disease. Nature. 2017;551(7682):585–9. doi:https://doi.org/10.1038/nature24628.PubMedPubMedCentral

89.

Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim). 2017;11(2):72–80.

90.

Wu YY, Xiao E, Graves DT. Diabetes mellitus related bone metabolism and periodontal disease. Int J Oral Sci. 2015;7(2):63–72. doi:https://doi.org/10.1038/ijos.2015.2.PubMedPubMedCentral

91.

Berthelot JM, Le Goff B. Rheumatoid arthritis and periodontal disease. Joint Bone Spine. 2010;77(6):537–41. doi:https://doi.org/10.1016/j.jbspin.2010.04.015.PubMed

92.

Vodanovic M, Peros K, Zukanovic A, Knezevic M, Novak M, Slaus M et al. Periodontal diseases at the transition from the late antique to the early mediaeval period in Croatia. Arch Oral Biol. 2012;57(10):1362–76. doi:https://doi.org/10.1016/j.archoralbio.2012.04.003.PubMed

93.

Chen LP, Chiang CK, Chan CP, Hung KY, Huang CS. Does periodontitis reflect inflammation and malnutrition status in hemodialysis patients? Am J Kidney Dis. 2006;47(5):815–22. doi:https://doi.org/10.1053/j.ajkd.2006.01.018.PubMed

94.

Shultis WA, Weil EJ, Looker HC, Curtis JM, Shlossman M, Genco RJ et al. Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care. 2007;30(2):306–11. doi:https://doi.org/10.2337/dc06-1184.PubMed

95.

Akar H, Akar GC, Carrero JJ, Stenvinkel P, Lindholm B. Systemic consequences of poor oral health in chronic kidney disease patients. Clin J Am Soc Nephrol. 2011;6(1):218–26. doi:https://doi.org/10.2215/CJN.05470610.PubMed

96.

Parkar SM, Ajithkrishnan CG. Periodontal status in patients undergoing hemodialysis. Indian J Nephrol. 2012;22(4):246–50. doi:https://doi.org/10.4103/0971-4065.101242.PubMedPubMedCentral

97.

Palmer SC, Ruospo M, Wong G, Craig JC, Petruzzi M, De Benedittis M et al. Dental health and mortality in people with end-stage kidney disease treated with hemodialysis: a multinational cohort study. Am J Kidney Dis. 2015;66(4):666–76. doi:https://doi.org/10.1053/j.ajkd.2015.04.051.PubMed

98.

Krishnan K, Chen T, Paster BJ. A practical guide to the oral microbiome and its relation to health and disease. Oral Dis. 2017;23(3):276–86. doi:https://doi.org/10.1111/odi.12509.PubMedPubMedCentral

99.

Lourenvarsigmao TGB, Spencer SJ, Alm EJ, Colombo APV. Defining the gut microbiota in individuals with periodontal diseases: an exploratory study. J Oral Microbiol. 2018;10(1):1487741. doi:https://doi.org/10.1080/20002297.2018.1487741.PubMedPubMedCentral

Titel: The Gastrointestinal Microbiome in Chronic Renal Diseases
verfasst von: Mark A. Bryniarski
Sarah E. M. Hoffman
Rabi Yacoub
Publikationsdatum: 14.01.2020
Verlag: Springer International Publishing
Erschienen in: Current Oral Health Reports / Ausgabe 1/2020
Elektronische ISSN: 2196-3002
DOI: https://doi.org/10.1007/s40496-020-00258-2

Neu im Fachgebiet Zahnmedizin

19.04.2024 | Vorhofflimmern | Nachrichten

Newsletter bestellen

Springer Medizin

The Gastrointestinal Microbiome in Chronic Renal Diseases

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

Newsletter

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Persistence of Tannerella forsythia and Fusobacterium nucleatum in Dental Plaque: a Strategic Alliance

The Buffalo OsteoPerio Studies: Summary of Our Findings and the Unique Contributions of Robert J. Genco, DDS, PhD

Periodontitis: a Host-Mediated Disruption of Microbial Homeostasis

The Role of the Oral Healthcare Team in Identification of Type 2 Diabetes Mellitus: A Systematic Review

The Oral Microbiome and Lung Diseases

Porphyromonas gingivalis: Immune Subversion Activities and Role in Periodontal Dysbiosis

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

Newsletter